Cite
HARVARD Citation
Edwards, C. et al. (n.d.). FRI0487 Apremilast is associated with long-term (4-YEAR) DAS-28 (CRP) remission and improvements in skin disease: results from a phase iii study in dmard/biologic-experienced patients with active psoriatic arthritis. Annals of the rheumatic diseases. p. 672. [Online].